DCM
DGX icon

Driehaus Capital Management’s Quest Diagnostics DGX Stock Holding History

Driehaus Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,453
Closed -$323K – 551
2017
Q3 		$323K Sell
3,453
-697
-17% -$74K 0.01% 436
2017
Q2 		$461K Buy
4,150
+380
+10% +$40.2K 0.02% 424
2017
Q1 		$370K Buy
3,770
+132
+4% +$12.6K 0.01% 457
2016
Q4 		$334K Buy
+3,638
New +$314K 0.01% 461

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Driehaus Capital Management's DGX Position: Q4 2017 in Review

Driehaus Capital Management sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 3,453 shares — an estimated $323K sold.

Driehaus Capital Management first reported a position in DGX in Q4 2016 and held it in 4 quarters. The position peaked at $461K in Q2 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Driehaus Capital Management reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Driehaus Capital Management sold 3,453 Quest Diagnostics shares in Q4 2017, an estimated $323K.
  • Driehaus Capital Management first reported a position in Quest Diagnostics in Q4 2016 and held it in 4 quarters.
  • Driehaus Capital Management's Quest Diagnostics position peaked at $461K in Q2 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Driehaus Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.